title: Chronic exposure to manganese alters brain responses to amphetamine: a pharmacological magnetic resonance imaging study.
abstract: The parkinsonian symptoms and increased Mn accumulation in dopaminergic (DAergic) neurons of the basal ganglia implicate impaired dopamine signaling in the neurotoxic effects of chronic manganese overexposure. Using blood oxygenation level-dependent (BOLD) pharmacological magnetic resonance imaging (phMRI), we mapped brain responses to acute amphetamine (AMPH; 3 mg/kg, ip), which stimulates midbrain DAergic systems, in male Sprague-Dawley rats following 6 weeks of chronic MnCl(2) (5 mg Mn/kg, one per week, iv) or saline treatment. Plasma Mn content, measured immediately following phMRI, was elevated twofold in Mn-treated animals (p < 0.05), but the twofold increase in mean striatal Mn content did not reach significance. In saline-treated animals, AMPH stimulated robust positive BOLD responses throughout the basal ganglia and their reciprocally innervated connections. In contrast, acute AMPH stimulated a negative BOLD response in many of these structures in the Mn-treated group, resulting in significant differences between saline- and Mn-treated AMPH-evoked BOLD responses within caudate putamen, globus pallidus, substantia nigra, mediodorsal thalamic nucleus, and somatosensory cortex. These results demonstrate the utility of AMPH-evoked phMRI as readout of the DAergic signaling in vivo and confirm the vulnerability of DAergic systems to Mn.
authors.affiliation: Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
authors.forename: Jason M
authors.initials: JM
authors.lastname: Williams
authors.forename: Dejan
authors.initials: D
authors.lastname: Milatovic
authors.forename: John C
authors.initials: JC
authors.lastname: Gore
authors.forename: Michael
authors.initials: M
authors.lastname: Aschner
authors.forename: Malcolm J
authors.initials: MJ
authors.lastname: Avison
mesh_terms: D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D001931:Brain Mapping; D002712:Chlorides / Q000097:blood / Q000633:toxicity*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D004336:Drug Antagonism; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D017895:Manganese Compounds / Q000097:blood; D010100:Oxygen / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D002712:Chlorides; D018765:Dopamine Uptake Inhibitors; D017895:Manganese Compounds; D000661:Amphetamine; C025340:manganese chloride; D010100:Oxygen